Aya Mhailan^1*, Israa Al-Rawashdeh¹, Ibrahim Kharboush² and Noordeen Shoqirat³

¹Department of Public Health and Community Medicine, Faculty of Medicine, Mutah University, Jordan.

²High Institute of Public Health, Alexandria University, Egypt

³Faculty of Nursing, Mutah University, Karak, Jordan.

Corresponding Author E-mail: Aya_mohilan@yahoo.com

DOI : https://dx.doi.org/10.13005/bpj/2407

Abstract

Background: There is a growing international development in community pharmacists’ and authority prescribing role. Objective: The study assess the attitudes of community pharmacists toward expanding their prescribing role and to identify any contributing factors. Methods: This cross-sectional study was conducted in Jordan.  A validated self-administered questionnaire addressing participants’ attitudes toward expanding the prescribing role of community pharmacists, the preferred model, barriers and training need was used. Results: In general, 62.3% of community pharmacists exhibited neutral attitudes toward expanding their prescribing role, and 79.4% favored the supplementary prescribing model. The key drivers for expanding prescribing were a better use of community pharmacists’ skills (88.7%) and drug knowledge (79.4%). However, the most perceived barriers were inadequate training in patient assessment and monitoring (75%) and diagnosis of disease (73%). Female respondents had higher mean attitude scores (65.5± 6.79) than males (63.1± 7.89),(p= 0.021, t=2.321). Respondents with a Pharm .D degree had higher mean attitude scores (68.0 ±9.19) than those with a postgraduate degree (66.3±7.59) or those with bachelor of pharmacy (63.6±6.88, p= 0.010, F=4.709). Conclusion: Although overall attitudes of community pharmacists toward prescribing role were neutral, there were some gaps in their knowledge and skills. Community pharmacists, therefore, require further and urgent training in certain areas together with addressing the identified barriers.

Keywords

Attitudes; Community pharmacists; Expanding prescribing; Independent prescribing; prescribing models

Download this article as: 

Copy the following to cite this article: Mhailan A, Al-Rawashdeh I, Kharboush I, Shoqirat N. Attitudes of Community Pharmacists towards Expanding their Prescribing Role: A Cross-sectional study. Biomed Pharmacol J 2022;15(2).

Copy the following to cite this URL: Mhailan A, Al-Rawashdeh I, Kharboush I, Shoqirat N. Attitudes of Community Pharmacists towards Expanding their Prescribing Role: A Cross-sectional study. Biomed Pharmacol J 2022;15(2). Available from: https://bit.ly/3muo5Q3

Introduction

Community pharmacists (CPs) have a unique position in the healthcare system, and their role is shaped by organizational, economic, and regulatory factors that may appear different worldwide ^1-3. Despite the differences in the pharmacists’ responsibilities in different contexts, their primary duties include ensuring that a patient’s drug therapy is managed appropriately and effectively, dispensing of drugs, and patient counseling ^{4, 5}.

A considerable body of evidence shows that pharmacists are moving from the traditional roles of only dispensing and counseling the medications to more advanced services and pharmaceutical care ^6-9. It is argued that there is a need to shift the pharmacy sector from product-oriented to patient-oriented through the expanding of pharmacists’ active role in patient-centered care, collaborative drug therapy management, and comprehensive medication safety systems ^{4, 10}.

The reviewed literature calls for expanding the access of healthcare delivery to all people around the world ¹¹.To this end, enabling healthcare professionals groups to prescribe with doctors was seen as a future strategy¹².That is, prescribing authority for these groups including the pharmacists was considered a significant development in the global healthcare system, especially with the growing needs of patients and increased prevalence of chronic and infectious diseases^{9, 13}.

It has become clear that expanding the pharmacists’ roles can benefit patients and pharmacists alike, as it is expected to improve the quality of care to patients, reduce long-term healthcare costs, optimize drug therapy, and to increase access to healthcare services, thus providing higher quality of patient-centered care ^14-16. For pharmacists, expanding their role is expected to improve their professional status  and authority leading to better utilization of their skills and knowledge, as well as increasing job satisfaction, self-confidence, and a reduction in physicians’ workload ^{9, 17, 18}.

Expanding the role of pharmacists according to their responsibility can be practiced in three key forms. The first form is the independent prescribing (IP), in which the pharmacist, who is the clinical management decision-maker, focuses on assessing conditions of diagnosed or undiagnosed conditions and without previous permission from other medical practitioners¹⁹. The second form is through supplementary prescribing (SP), which includes an agreed partnership between a doctor or dentist, a patient and a supplementary prescriber who, inturn, can prescribe within the patient’s specific clinical management plan²⁰.The third form is the collaborative prescribing model, in which “a collaborative practice agreement between one or more physicians and pharmacists, that the qualified pharmacists working among the context of a defined protocol are permitted to assume professional responsibility for performing patient assessments; ordering drug therapy related laboratory tests; administering drugs; and selecting, initiating, monitoring, continuing, and adjusting drug regimens.”⁹

Internationally it seems that there is a disparity in the adoption of these models. One or more of these three models was/were implemented in the United States (USA), Canada, and the United Kingdom (UK) ^{12, 21}. In the UK, a supplementary prescribing model including pharmacists was adopted in 2003; after that, the independent prescribing model was implemented for the supplementary prescriber within specific criteria such as training, testing, and certification ^{17, 22}. In the USA, pharmacists are involved with doctors in a collaborative drug therapy management model⁹.

In a less developed context, significant differences in the pharmacy profession appear to present compared to the developed ones. In Jordan, as in many Arab countries, pharmacists can prescribe medications listed as Over The Counter (OTC) medications²³. The role of pharmacists in Jordan has been expanded over the past 20 years from merely dispensing and marketing of drugs to include more clinically-oriented roles[24].In support of this transition, Jordan has established education programs specific to the pharmacy profession, such as a 6-year Pharmacy Doctor (Pharm .D) program and Masters programs in clinical pharmacy²⁴. These programs imply a great emphasis on pharmacists’ clinical roles and the expansion of their duties in Jordan^4,25.

To date, however,  the available data  on the expansion of CPs role using models of prescribing have  mostly came  from the developed countries^{26, 27}. Moreover, the literature about attitudes toward pharmacists prescribing and related factors in the Arab world is limited. Thus, decision and policy makers face a dilemma of a dearth data to enhance and expand future community pharmacists’ role in prescribing. Given the differences in healthcare system, education, curricula, and population characteristics, the cross applicability to the community pharmacists in Jordan might have limitations. Consequently, this study aims to explore community pharmacists’ attitudes toward their role in supplementary and independent prescribing as expanded roles of pharmaceutical professional practice in Jordan, and to identify the contributing factors for their attitudes.

Methods  

Study design, Setting and participants

A descriptive cross-sectional study was conducted in Amman, the capital of Jordan, during the period from December 2019 to March 2020 using a self-administered questionnaire. The highest number of community pharmacies in Jordan is located mostly in Amman⁴. Email permission was obtained from the first author, “kreshnikHoti”, to use a previously developed questionnaire and carry out any revisions needed to suit the Jordanian context. Moreover, ethical approval for the study was obtained from the Faculty of Medicine and the Faculty of Graduate Studies at [X] University and subsequently from the Jordan Pharmacists Association (JPA). Eligible participants were licensed pharmacists working in community pharmacies in Jordan. Participation in the study was voluntary and was no risk involved to the participants.

Survey development

The questionnaire to measure the attitudes of CPs toward expanding their role was developed based on Hoti et al.’s (2010)’s study²⁸. The study explores the pharmacists’ attitudes toward expanding their prescribing role in Australia with some modifications to suit the Jordanian target population and pharmaceutical health system. The questionnaire was administered in Arabic language since Arabic is the mother tongue for the CPs in Jordan. The translation from English to Arabic was done using the guideline for the Process of Cross-Cultural Adaptation of Self-Report Measures to ensure the translation equivalency and appropriateness of the questionnaire²⁹. To ensure face validity, expert panels consisting of five experts having previous experience in pharmacy practice revised the author’s modifications on the questionnaire. Accordingly, some question adjustments were made to the questionnaire to improve the validity and answer the research questions of the study.

Deleting the fourth statement in section four of the questionnaire, “Pharmacists should be able to prescribe for 30-day emergency supply, rather than current 3-day limit. ”This regulation was found only in Australia and not in Jordan, according to Jordan Pharmaceutical Association law No.51 of 1972 and Drug and Pharmacy law No.12 of 2013³⁰.

Deleting statement number six in section five, “Potential for increased government cost.” This is because the private sectors own all the community pharmacies in Jordan, and the government only owns public pharmacies in the governmental hospital³⁰.

Deleting statement number four in section nine, “I believe medicines prescribed from an expanded role and consultations should be claimable from Medicare” as this statement is related to the national insurance system in public and private sectors in Australia and not applicable  to  Jordan³¹. Then, the researcher reviewed all the suggestions and integrated them into the pre-final version of the questionnaire.

The pre-final research questionnaire was pilot tested with a random selection sample of (n=30) of community pharmacists in the nine counties in Amman. The purpose of the pilot study was to make sure that:  the statements were understandable, the language was simple and straightforward, determine the time needed for data collection, length of a questionnaire, and any difficulty faced when completing the survey. All the questionnaires at this stage were excluded from the final analysis of the main study. After piloting modifications were made in the questionnaire, the researcher tested the extent of the paragraphs’ internal consistency depending on the pilot sample (n=30). The Cronbach’s alpha value for the whole questionnaire was satisfactory (0.81).

The final version of the questionnaire consisted of 10 sections exploring various domains related to CPs’ attitudes toward expanding their roles. The participants’ responses to these sections used Likert scale answers, i.e. “Agree,” “Neutral,” “Disagree, ”in addition to Yes/no questions. The first section included questions sought to obtain respondents’ demographic and job characteristics. The second section covered CPs’ attitude toward expanding pharmacy professional services and pharmacists prescribing, while the third section was related the CPs’ attitude to their clients’ reaction toward the expansion of their prescribing role. The fourth section was about CPs’ attitude to the drivers of expanding the CPs’ prescribing role. The fifth section was about prescribing models the CPs’ preferred. The sixth section was about the attitude of CPs’ toward the barriers of expanding pharmacist prescribing, with the  section also containing two (yes/no) questions; the first to know if they thought CPs should have expanded prescribing rights, and the second one to know if the CPs wished to take an expanding role in prescribing. The seventh section contained two sub-sections for expanding prescribing using the supplementary model and the independent model. Under each subsection, a number of chronic conditions were listed.

The eighth section had one (yes/no) question to know if the CPs would need further training. If answered yes, a further three sub-sections followed, the first regarding six therapeutic topics they might need training in. The second sub-section addressed training areas and the third sub-section addressed training issues such as doctors’ supervision, continuing education, specializing in clinical areas, and specialist registration. The ninth section concerned the CPs’ attitude toward the implications of pharmacists prescribing on pharmacy infrastructure and, finally, the tenth section focused on the CPs’ attitude to expanding their roles in the management of minor ailments.  

Sample size

The sample size was determined using Open Epi, based on the total number of Jordan Pharmaceutical Association registered pharmacists in Amman during the time of this study, which was 11318[4].The minimum sample size needed was 201; this was  calculated to achieve 95% level of confidence and 5% marginal error. However, the researcher added 20% (n=44) on the minimum number and distributed randomly a number of  245  questionnaires; 14 pharmacists refused to fill in the questionnaire, with a response rate of 94.3%. Additionally, 27 questionnaires which had missing data were excluded from the statistical analyses. The final number of the analyzed questionnaires without missing data was 204.

Survey implementation

The capital of Jordan, Amman is divided into nine counties, and the data were collected from these  in proportion to the number of community pharmacies in each county. The researcher visited the selected pharmacies in person, through working hours of the day (i.e., day shifts), and during all days of the week. Based on the covering letter, the  study’s purpose and instruction were presented on the front page of the questionnaire to ensure that the same information was delivered to all participants. In addition, participants were informed that all information provided by them would be kept secret and be used only for research purposes.  Once participants agreed to participate verbally, the questionnaires were distributed to them to be filled out. During data collocation, participants were recruited with the aim of heterogeneity regarding gender, years of work experience, and age. The questionnaire took about 10 to 15 minutes to complete, was collected directly or dropped, and picked up later after being completed by the pharmacists who did not have time to fill it there and then. 

Statistical Analysis

Statistical Package for Social Sciences (SPSS) database for Windows version 23 was used for data entry and analysis. Any missing data were excluded from the analysis. Descriptive statistical analysis was used to summarize demographic data and responses to the questionnaires (frequencies and percentage for categorical variables, means and standard deviations were also calculated). The statistical t-test was applied to compare the means of Likert scale variables where the independent variables had two categories (e.g., gender and owner of the pharmacy). Analysis of Variance (ANOVA) was used to compare the means of Likert scale variables where the independent variables had more than two categories (Age, years of experience, highest degree achieved, and type of graduation country).In addition, the appropriate post hoc test, which is the least significant difference (LSD), was applied. A total attitude score was computed out of 100 to indicate the respondents’ attitudes. The attitude scores were interpreted into three categories as follows: from 0 to 33.3 indicates a negative attitude, from 33.4 to 66.6 indicates a neutral attitude and from 66.7 to 100 indicates a positive attitude.

Results

The CPs mean age was 30± 6.95 years. A little more than half of the respondents were females (53.9%). Slightly half of the respondents were registered as pharmacists for less than five years (52.9%). About 78.4% of the respondents held a Bachelor’s degree in pharmacy, 12.3% had bachelor’s degree of Pharm. D and 9.3% had Masters or PhD (Table 1).

Table 1: The sociodemographic and work characteristics of the community pharmacists participating in the study (n=204).

Parameter	n(%)
Gender Male Female	94(46.1)
	110 (53.9)
Age(Years) 24-23 35-45 46-56 More than 56	159 (77.9)
	39 (19.1)
	3 (1.5)
	3 (1.5)
Registration years in JPA ˂1 1-5 6-10 11-15 ˃15	20 (9.8)
	108 (52.9)
	40 (19.7)
	19 (9.3)
	17 (8.3)
Work years ˂1 1-5 6-10 11-15 ˃15	27 (13.2)
	104 (51.0)
	38 (18.7)
	19 (9.3)
	16 (7.8)
University graduation Governmental Private Outside Jordan	64 (31.4)
	129 (63.2)
	11 (5.4)
Graduation country Egypt Iraq Jordan Pakistan Philippines Russia	7 (3.4)
	1 (0.5)
	193 (94.6)
	1 (0.5)
	1 (0.5)
	1 (0.5)
Highest degree achieved Bachelor of Pharmacy Bachelor of Pharm-D Master degree PhD	160 (78.4)
	25 (12.3)
	18 (8.8)
	1 (0.5)
Type of pharmacy Independent Pharmacy Chain Pharmacy	185 (90.7)
	19 (9.3)
Ownership Non owner Owner	176 (86.3)
	28 (13.7)
Workload Small (˂100 patients/day) Large (˃100 patients /day)	90 (44.1) 114 (55.9)

 

The results showed that 34.4% of the CPs agreed that the pharmacy profession needs to expand its scope of professional services. Furthermore, 42.7% of the CPs viewed themselves in the future as having more expanded prescribing responsibilities. However, the results also revealed that 44.6% are satisfied with the limited current prescribing role. With regard to customer reaction for pharmacists prescribing, almost two thirds of CPs reported that the customers would accept pharmacists with an expanded prescribing role (68.6%). CPs also perceived that the customers would have safer access to their medications if pharmacists were prescribers (65.2%), and believed that customers may find it easier to access pharmacists than GPs and, therefore, would prefer CPs to have an expanded role (67.6%). Additionally, 81.9% agreed that the customers would trust pharmacists as prescribers (Table 2).

Table 2: The attitudes of study participants towards customers’ reaction to expanding their prescribing role (n=204).

Item	Disagree	Neutral	Agree
	%	%	%
Customers would accept pharmacists with an expanded prescribing role.	4.4	27.0	68.6
Customers would trust pharmacists as prescribers.	2.5	15.6	81.9
Customers would have safer access to their medications if pharmacists were prescribers.	5.9	28.9	65.2
Customers find accessing their GP too difficult and may prefer pharmacists to have an expanded prescribing.	7.8	24.6	67.6
Customers appreciate pharmacists’ advice and prefer CP as prescribers.	3.4	14.7	81.9

 

The way CPs believe pharmacists should assume the expanded prescribing role was examined and about 79.4% of the CPs agreed on the supplementary model as the most suitable model for expanding the prescribing role. The second most agreed-upon model was to expand the prescribing based on the current OTC drug list and additional limited drug list (63.2%), whereas36.8% of CPs supported the independent prescribing model. More than half of all respondents (53.4%) did not agree that expanding the prescribing role should be limited only to the hospital pharmacists(Table 3).

Table 3: The attitudes of study participants to the way they believe pharmacists should assume expanded the prescribing role (n=204).

Item	Disagree	Neutral	Agree
	%	%	%
Independent prescribing model.	35.3	27.9	36.8
Supplementary prescribing model.	13.2	7.4	79.4
Pharmacists should be able to prescribe from a limited drug formulary, which would include the current OTC list and additional limited drugs list.	12.3	24.5	63.2
I believe any possible future expanded prescribing should be done by Hospital Pharmacists only.	53.4	20.1	26.5

 

The analysis revealed the   driving factors that would encourage pharmacists’ prescribing. More than two thirds of CPs,77.0%, perceived expanded prescribing responsibilities to be a direction that the pharmacy profession should adopt to ensure an advanced role in healthcare. Respondents also highly agreed (79.4%) that they had the required drug knowledge that qualifies them to assume more prescribing responsibilities. Furthermore, 88.7% of CPs felt that prescribing will enable better use of pharmacists’ professional skills, while 78.4% of the CPs demonstrated that expanding prescribing will increase the pharmacy profit, as shown in Table 4.

Table 4: The attitude of study participants towards the drivers for expanding pharmacists prescribing (n=204).

Item	Disagree	Neutral	Agree
	%	%	%
I believe customers would have better access to their medications if pharmacists were prescribers.	5.9	26.5	67.6
Expanded pharmacist prescribing would ease the burden from overloaded GP’s and hence improve the functioning of our health system.	2.9	25.0	72.1
An expanded prescribing responsibility is a direction that the Pharmacy profession should be headed to secure a more important role in health care.	3.4	19.6	77.0
Pharmacists are highly regarded by the community, and therefore, they should assume more prescribing.	6.9	22.5	70.6
Pharmacists have the necessary drug knowledge to assume more prescribing	5.4	15.2	79.4
Pharmacists have the necessary patient assessment skills to assume more prescribing responsibilities.	6.8	27.0	66.2
Pharmacist prescribing enables better use of pharmacist’s professional skills.	1.5	9.8	88.7
Expanded prescribing will contribute to increased Pharmacy profits.	6.4	15.2	78.4

 

Inadequate training in diseases’ diagnosis (if this was the pharmacist’s responsibility) was the highest reported barrier to expanded prescribing amongst the CPs (73%). Similarly, 75% of the respondents agreed that pharmacists have inadequate training to assess and monitor patients.  More than half of the CPs (52%) believed that expanding prescribing can lead to confusion regarding the GPs and pharmacists’ roles from the public side, while 44.1% agreed that CPs may have a commercial interest in prescribing. Inadequate facilities in pharmacies could be a barrier for prescribing as reported by 46% of CPs, while 65.2% viewed the increased potential of litigation as another barrier for expanding prescribing for pharmacists (Table 5). In relation to the above, when respondents were asked, “Do you think pharmacists should have expanded prescribing rights?” almost all of them answered “yes”,  97.1%.

Table 5: The attitudes of study participants to the barriers that could limit expanded prescribing (n=204).

Item	Disagree	Neutral	Agree
	%	%	%
Inadequate training in the diagnosis of disease (if this were the pharmacist’s responsibility).	2.5	24.5	73.0
Inadequate training in patient assessment and patient monitoring.	5.9	19.1	75.0
Potential for a reduction in the quality of patient care.	27.0	29.4	43.6
Potential for increased patient costs.	39.2	30.8	30.0
Potential for increased hospital admissions.	27.5	41.1	31.4
Conflict of interest with pharmacists acting both as prescribers and dispensers.	26.0	25.0	49.0
Pharmacists’ lack of time.	38.2	30.4	31.4
Increased confusion amongst the public as to the role of GP’s and pharmacists.	20.1	27.9	52.0
Potential decrease in the quality of current services offered by pharmacists.	32.4	29.9	37.7
Pharmacists having a commercial interest in prescribing.	24.0	31.9	44.1
Inadequate facilities within pharmacies to allow pharmacist prescribing.	27.0	27.0	46.0
Increased likelihood of litigation.	9.3	25.5	65.2

 

The overwhelming number of respondents (97.1%), who answered yes to expanding pharmacists’ prescribing, reported “Pain management” as the most chronic condition in which  pharmacists should have an expanded prescribing role in the form of supplementary prescribing (83.3%). Most CPs (79.2%) mainly believed that pharmacists can prescribe a limited range of antibiotics using a supplementary prescribing model. Asthma and other respiratory conditions were the third common condition reported by respondents. In the form of an independent prescribing role, CPs showed a moderate agreement on expanding prescribing for conditions of pain management and antibiotics (61.6%, 52.5%), respectively.

The majority of  CPs (91.7%)  highlighted the need for more training to expand their prescribing role. Three areas were highly ranked as top training needs for expanding the prescribing role by the respondents: clinical pharmacology, the pathophysiology of conditions, physiological changes and drug response in different age groups. Additionally, the CPs agreed the need to be trained in the following areas: principles of diagnosis (72.1%), evidence-based practice (72.7%), principles and methods of patient monitoring (78.0%), and public health issues (70.5%). More than a third of CPs reported no need for a specialist registration at regulation bodies (43.3%) and no need for supervision by a medical practitioner (42.7%). Moreover, only 19.7% of CPs agreed with the need for training on “Demonstration of relevant Continuing Education that ensures their prescribing skills are kept to date”.

The majority of CPs (84.3%) believed that the current staff arrangements in the pharmacy can support expanded pharmacist prescribing. But 81.4% of them agreed on the need to create a separate quiet consulting area for pharmacist prescribing. Furthermore, 75% focused on pharmacists’ need for an additional IT resource in the pharmacy to support pharmacist prescribing. On the other hand, only 40.7% of the respondents believed that pharmacists’ independent prescribing should not occur in a community pharmacy (Table 6).The results  revealed that 62.3 % (n=127) of the respondents’ total attitudes scores were higher than 33.4 and less than 66.6, which represents neutral attitudes, whereas 37.7 % (n=77) of the respondents’ total scores were higher than 66.7 and less than 100, which is interpreted as a positive attitude.

Table 6: The attitudes of study participants towards implications of pharmacist prescribing on pharmacy infrastructure (n=204).

Item	Disagree	Neutral	Agree
	%	%	%
I believe additional IT resources in the Pharmacy would be needed to support pharmacist prescribing.	4.9	20.1	75.0
I believe I have access to sufficient patient information in order to make prescribing decisions for them.	7.4	21.6	71.1
I believe prescribing and dispensing should be carried out in separate areas in the Pharmacy.	6.9	26.5	66.7
I believe a separate quiet consulting area for pharmacist prescribing should be created in the Pharmacy.	6.4	12.3	81.4
I believe current staff arrangements in the Pharmacy can support expanded pharmacist prescribing.	2.9	12.7	84.3
I believe independent prescribing by a pharmacist should NOT occur in community pharmacy (excluding OTC drugs).	28.9	30.4	40.7

 

The overall mean of respondents’ attitude toward their expanding role in prescribing was 64.4 ±7.39. The attitudes of community pharmacists toward the drivers for expanding prescribing had the highest mean domain score by respondents (72.99±11.54). This was followed by the domain of pharmacists’ attitude toward customer reaction to expand pharmacists prescribing (71.32±13.36). The results showed that the neutral attitudes of CPs were expressed toward the domain of the reasons they believe pharmacists should not have expanded prescribing rights (58.30±14.66). Finally, among the neutral attitudes, the least score was for the domain of the way they see the future of the pharmacy profession (53.92±22.7) (Table 7).

Table 7: The overall scores of attitude domains of community pharmacists towards expanding their role (n=204).

No.	Domains	Negative %	Neutral %	Positive %	Mean	SD
1	Attitude of CP to the way they see the future of the Pharmacy profession.	21.1	47.1	31.9	53.92	22.77
2	Attitude of CP based on their experience in Pharmacy towards customer reaction to expand pharmacists prescribing.	1	35.3	63.7	71.32	13.36
3	Attitude of CP to reasons for pharmacist prescribing.	0	29.4	70.6	72.99	11.54
4	Attitude of CP to the way they believe pharmacists should assume expanded prescribing responsibilities.	12.3	54.9	32.8	58.03	16.56
5	Attitude of CP to the reasons they believe pharmacists should not have expanded prescribing rights.	8.3	67.6	0.24	58.30	14.66
8	Attitude of CP to the implications of pharmacist prescribing on pharmacy infrastructure.	2	36.3	61.8	69.37	12.25
9	Attitude of CP to the extension of pharmacists’ current roles in the management of minor ailments.	2.9	35.3	61.8	66.97	15.54
Total attitude of CP		0	64.7	35.3	64.41	7.394

 

The analyses of the relationship between community pharmacists’ attitudes toward expanding their prescribing roles and sociodemographic factors show that female respondents had higher mean attitude scores (65.5± 6.79) than males (63.1± 7.89). This difference was statistically significant (p= 0.021, t=2.321). Respondents with a Pharm. D degree had higher mean attitude scores (68.0 ±9.19) than those with a postgraduate degree (66.3±7.59) or those with Bachelor of Pharmacy (63.6±6.88). This difference was statistically significant using ANOVA test (p= 0.010, F=4.709). LSD test showed that respondents with a Pharm. D degree hada more positive attitude than counterparts having  a Bachelor of Pharmacy degree (P=0.005).

Discussion

The aim of this cross-sectional study was to explore the attitudes of community pharmacists toward the potential implementation of pharmacist prescribing in Jordan. Our results find that the overall attitudes of CPs toward expanding their potential role in prescribing were neutral (62.3%).These results are largely inconsistent with the existing body of literature and, thus, need to be interpreted carefully within the national and international context. The results are in particular incongruent with a recent  Jordanian study where it was found that the majority of pharmacists (92.5%) had positive attitudes toward the expanded prescribing role³². Similarly, the current results  do not resonate with those emerged from a Qataristudy which found  that  the overwhelming majority   of pharmacists,94.4%,   reinforced the idea of expanding their prescribing role [33]. However, from a wider perspective, international studies from Australia, Scotland, and Nigeria  showed  more positive attitudes than the current study (83.9%, 97.7% and 97.1%, respectively)^{13, 28, 34}.

This could be due to the fact that the current study focused exclusively  on community pharmacists whilesome of the previous studies did not have such focus.   For instance, in Nusair et al.’s (2020) study, the results reflected the attitudes of CPs in addition to hospital pharmacists³². Previous research found that hospital pharmacists focus more on knowledge of drugs and areas of laboratory tests than community pharmacists³⁵. In addition, it was found that hospital pharmacists have attitudinal differences from the community pharmacists regarding drivers, barriers, and models of pharmacists prescribing³⁶. Given the differences between hospital and community pharmacists in terms of training and policies, their attitudes toward prescribing roles might be shaped accordingly.

Another explanation for such differences might be attributed to the early introduction of the legislation in some countries supporting pharmacist prescribing, along with the training programs for expanding prescribing¹². Therefore, pharmacists’ attitudes can vary according to the different settings, legislations of the countries, and the nature of pharmacists’ training.

However, it is noteworthy to mention that, while the overall attitudes in this study were neutral, the majority of respondents (97%) answered yes to the specific question “’Do you think pharmacists should have expanded prescribing rights? ”This could imply a gap in the understanding of the expansion of roles by the CPs as they agree with expansion in general, but, when attitudes toward these expanded roles in details are examined, neutral attitudes are more shown. Nevertheless, this finding raises questions about what might be carried out in the name of perceived prescribing role of CPs and calls for further research.

The current study showed that the majority of the community pharmacists prefer the adoption of the supplementary model (79.4%). This is similar to many previous studies where pharmacists preferred the supplementary model, and in particular over the independent model^{13, 32, 37, 38}.However, to some extent, it could be challenging to make comparisons between these studies, in that the available evidence reports attitudes of combined groups of non-medical prescribers such as nurses, pharmacists and allied healthcare professionals, which could have led to different results than our findings. However, to some extent, the agreement on the supplementary model among the population of this study fits well with the overall neutral attitudes of community pharmacists regarding their prescribing role and the uncertainty they might perceive regarding their ability to be independent prescribers.  In other words, community pharmacists in the current study might be more comfortable to work with a supplementary model that still depends on the doctor’s shared advice as opposed to the independent prescribing model.

Furthermore, the current study results are consistent with Jebara’s (2019) framework for the development of pharmacists prescribing in Qatar. The study found no support to implement an independent pharmacists prescribing model in Qatar due to concerns over pharmacist diagnosis skills and the relative immaturity of pharmacy practice³⁹.These results could be beneficial to the Jordanian context due to many similarities in education, culture, and people.  Nevertheless, the supplementary model could be a starting point for a more advanced future independent model. For example, the successful UK model for pharmacists prescribing started with supplementary prescribing in 2003 as a foundation stone for implementing an independent model in 2006 ^{14, 40}.

It should be noted in this study that about 83.3% of CPs strongly agreed to the supplementary prescribing of chronic pain management. This postulates that CPs in the current study might be keener to expand their prescribing role to address pain management and minor infections as opposed to more severe and chronic cases. This is in line with the rules and regulations in Jordan, which emphasize that prescribing by pharmacists needs to be limited for minor conditions only, such as minor infections, cold, fever, pain, and prohibits pharmacists prescribing for more severe chronic conditions⁴¹

In this study, CPs perceived customers to trust pharmacists as prescribers. It is worth mentioning that literature from Jordan also documents that many Jordanian patients are willing to practice self-medication and purchase medications, particularly antibiotics, from pharmacies without prescriptions due to the socioeconomic factors and to save time and cost^{42, 43}. These arguments are substantiated by the current results, where 65.2% of pharmacists believe that customers would have safer access to their medication if pharmacists were prescribers, which could decrease the practice of self-medication in Jordanian society.

In light of the above, and to understand how community pharmacists in Jordan can activate their prescribing role in the future, contributing barriers need to be uncovered. The majority of respondents (91.7%) expressed their needs for further training. The areas of training in expanding the prescribing role included clinical pharmacology. Previous studies in Jordan and Qatar showed similar findings^{32, 33}.However, others believe that a lack of training in prescribing reflects the fact that pharmacists traditionally have no role in clinical diagnosis and treatment¹².

The problem, as  it seems in this study, is that  respondents perceived inadequate training in patients’ assessment skills (75%) and diagnosis of diseases (73%) as the main barriers for pharmacists to adopt a prescribing role, which is similar to previous researches^{13, 28, 32}. Therefore, there is a need to focus on developing and accessing new teaching systems, including workshops and computerized simulations to match the training needs of CPs in clinical pharmacology, medical diagnosis, and assessment.

The relationship between specialized programs, training, and community pharmacists’ attitudes toward prescribing was evident in our study.  It was found that respondents with a 6-yearPharm.Ddegree hold more positive attitude than other counterparts who have a 5-yeardegree (Bachelor of Science in Pharmacy) (p= 0.010, F=4.709). This might be because a Pharm.D. program is more supportive for the adoption of expanding pharmacists prescribing because it fundamentally emphasizes pharmaceutical care that includes patient care and clinical pharmacy than the BSc.in Pharmacy program[44, 45]. In light of the above discussions, the study showed that community pharmacists are keen to adopt a supplementary prescribing role. Enabling such a role in daily contact with the community can be seen as the first step on the ladder of pharmaceutical reform.  This is, however, not a straightforward objective to achieve.

Changing policies of pharmacists prescribing by focusing on integrating community pharmacists into primary care services, developing a vision for different levels of pharmacist services, and developing new remuneration schemes for these services is required. Therefore, it would be beneficial to explore other stakeholders’ attitudes toward expanding of pharmacists prescribing. Finally, qualitative research and mixed-method approach in the future is needed to uncover pharmacists’ experiences toward the prescribing role in greater depth. The emerging data from the current study might be used to guide such approach.

While this study offers wide insights into how CPs perceive their future expanding role in prescribing, it suffers from some limitations.  The study results are exclusively based on the perspectives of community pharmacists. The study sample was from the capital Amman, which may differ from other remote areas in Jordan in terms of  sociodemographic characteristics and community pharmacies’ distribution. However, Amman  contains the highest density of community pharmacies in Jordan, and, thus, it is hoped  that the results could be used as a springboard for guiding future prescribing  policies and stimulate further international debate in this largely unexplored area.

Conclusion 

The study provides essential insights into community pharmacists’ attitudes toward expanding prescribing role and those contributing factors. Although CPs showed strong agreement for expanding their future prescribing role, the overall attitudes were neutral.  CPs were also in favor of a supplementary prescribing model compared to other models,  such as an  independent model. Pharmacists’ competent skills and knowledge to prescribe, increasing the pharmacy profits, and the perceived trust by their clients were the main drivers for their future expanding prescribing. However, in reality, the lack of training in the diagnosis and patient assessment, increase in the likelihood of litigation, and the absence of a consultation room might  inhibit adopting expanding prescribing role in Jordan. The data can provide evidence to regulatory bodies such as Jordan Pharmacists Association and Jordan Medical Association and Stakeholders of healthcare services and policies to reform pharmacies within the community toward an expanded pharmacist prescribing role.  This cannot be achieved unless barriers uncovered in this study are well-understood and addressed in the future reform strategy for community pharmacists’ expanded role in prescribing.

Acknowledgment

None

Conflict of Interest

There are no conflict of interest.

Funding Sources

There is no funding source.

References

1. Abu Farha R, Abu Hammour K, Mukattash T, Alqudah R, Aljanabi R. Medication histories documentation at the community pharmacy setting: A study from Jordan. PloS one. 2019;14(10):e0224124. https://DOI: 1371/journal.pone.0224124
   CrossRef
2. Alhaddad MS. Youth experience with community pharmacy services and their perceptions toward implementation of medication therapy management services by Community Pharmacists in the Western Region of Saudi Arabia. Therapeutic innovation & regulatory science. 2019;53(1):95-99. . https://DOI: 1177/2168479018769299
   CrossRef
3. Altman IL, Mandy PJ, Gard PR. Changing status in health care: community and hospital pharmacists’ perceptions of pharmacy practice. International Journal of Pharmacy Practice. 2019;27(3):249-255.https://DOI:1111/ijpp.12505
   CrossRef
4. Al-Qudah RA, Tuza O, Tawfiek H, Chaar B, Basheti IA. Community pharmacy ethical practice in Jordan: assessing attitude, needs and barriers. Pharmacy Practice (Granada). 2019;17(1). . https://DOI: 10.18549/pharmpract.2019.1.1386.
   CrossRef
5. Alsharif NZ, Khanfar NM, Brennan LF, et al. Cultural Sensitivity and Global Pharmacy Engagement in the Arab World. American journal of pharmaceutical education. 2019;83(4).DOI: https://doi.org/10.5688/ajpe7228.
   CrossRef
6. Amariles P, Sorio-Bedoya EJ, Cardona D. Teaching of pharmaceutical care in Latin America: a structured review. Farmacia hospitalaria: organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 2019;43(2):66-73. . https://DOI: 10.7399/fh.11193.
7. Lee SWH, Bell JS. Pharmaceutical care in Asia. The Pharmacist Guide to Implementing Pharmaceutical Care: Springer; 2019:191-197. . https://DOI: 10.1007/978-3-319-92576-9_17.
   CrossRef
8. Low HMM, Lai YF. Understanding and expectation towards pharmaceutical care among patients, caregivers and pharmacy service providers: a qualitative study. European Journal of Hospital Pharmacy. 2020;27(1):25-30. . https://DOI:1136/ejhpharm-2017-001415.
   CrossRef
9. Center for Disease Control and Prevention. Pharmacy: Collaborative Practice Agreements to Enable Collaborative Drug Therapy Management. website. https://www.cdc.gov/dhdsp/pubs/guides/best-practices/pharmacist-cdtm.htm. Published 2019. Accessed 2021,Sept.
10. Al-Ghananeem AM, Malcom DR, Shammas S, Aburjai T. A call to action to transform pharmacy education and practice in the Arab world. American journal of pharmaceutical education. 2018;82(9).DOI: https://doi.org/10.5688/ajpe7014.
    CrossRef
11. Alsabbagh MW, Houle SK. The proportion, conditions, and predictors of emergency department visits that can be potentially managed by pharmacists with expanded scope of practice. Research in Social and Administrative Pharmacy. 2019;15(11):1289-1297. . https://DOI:1016/j.sapharm.2018.12.003.
    CrossRef
12. Zhou M, Desborough J, Parkinson A, Douglas K, McDonald D, Boom K. Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences. International Journal of Pharmacy Practice. 2019;27(6):479-489. . https://DOI:1111/ijpp.12557.
    CrossRef
13. Auta A, Strickland‐Hodge B, Maz J, David S. Pharmacist prescribing: a cross‐sectional survey of the views of pharmacists in Nigeria. International Journal of Pharmacy Practice. 2018;26(2):111-119. https://DOI:1111/ijpp.12381.
    CrossRef
14. Jebara T, Cunningham S, MacLure K, et al. Key stakeholders’ views on the potential implementation of pharmacist prescribing: A qualitative investigation. Research in Social and Administrative Pharmacy. 2020;16(3):405-414. https://DOI:1016/j.sapharm.2019.06.009.
    CrossRef
15. Rosenthal MM, Houle SK, Eberhart G, Tsuyuki RT. Prescribing by pharmacists in Alberta and its relation to culture and personality traits. Research in Social and Administrative Pharmacy. 2015;11(3):401-411. https://DOI: 1016/j.sapharm.2014.09.004.
    CrossRef
16. Weeks G, George J, Maclure K, Stewart D. Non‐medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care. Cochrane Database of Systematic Reviews. 2016(11). https://DOI:1002/14651858.CD011227.pub2.
    CrossRef
17. Cope LC, Abuzour AS, Tully MP. Nonmedical prescribing: where are we now? Therapeutic Advances in Drug Safety. 2016;7(4):165-172. https://DOI:1177/2042098616646726.
    CrossRef
18. Sadek MM, Elnour AA, Al Kalbani NM, et al. Community pharmacy and the extended community pharmacist practice roles: The UAE experiences. Saudi Pharmaceutical Journal. 2016;24(5):563-570. https://DOI:1016/j.jsps.2015.03.023.
    CrossRef
19. Tsuyuki RT, Watson KE. Why pharmacist prescribing needs to be independent. SAGE Publications Sage CA: Los Angeles, CA; 2020. https://DOI:1177/1715163520904366
    CrossRef
20. Health and care professions council. Standards for prescribing. website. https://www.hcpc-uk.org/standards/standards-relevant-to-education-and-training/standards-for-prescribing/. Published 2018. Accessed 2021,June.
21. Dawoud D, Griffiths P, Maben J, Goodyer L, Greene R. Pharmacist supplementary prescribing: a step toward more independence? Research in Social and Administrative Pharmacy. 2011;7(3):246-256. https://DOI:1016/j.sapharm.2010.05.002.
    CrossRef
22. Hindi AM, Seston EM, Bell D, Steinke D, Willis S, Schafheutle EI. Independent prescribing in primary care: A survey of patients’, prescribers’ and colleagues’ perceptions and experiences. Health & social care in the community. 2019;27(4):e459-e470. https://DOI:1111/hsc.12746.
    CrossRef
23. Bader LR. Developing the capacity of pharmacists in Jordan: Progress, challenges and opportunities, University of Nottingham; 2017.
24. Abu Asab MI, Abushams L, Albsoul-Younes A, Wazaify M. ” A Decade in Leaps and Bounds”: Pharmacy in Jordan-revisited. Jordan Journal of Pharmaceutical Sciences. 2019;12(3).
25. Hammad EA, Qudah RA, Akour AA. The impact of clinical pharmacists in improving Jordanian patients’ health outcomes. Saudi Medical Journal. 2017;38(11):1077. https://Doi: 15537/smj.2017.11.21453
    CrossRef
26. Bryant L, Maney J, Martini N. Changing perspectives of the role of community pharmacists: 1998–2012. Journal of Primary Health Care. 2017;9(1):34-46. https://DOI:1071/HC16032.
    CrossRef
27. Schindel TJ, Yuksel N, Breault R, Daniels J, Varnhagen S, Hughes CA. Pharmacists’ learning needs in the era of expanding scopes of practice: Evolving practices and changing needs. Research in Social and Administrative Pharmacy. 2019;15(4):448-458. https://DOI:1016/j.sapharm.2018.06.013.
    CrossRef
28. Hoti K, Sunderland B, Hughes J, Parsons R. An evaluation of Australian pharmacist’s attitudes on expanding their prescribing role. Pharmacy world & science. 2010;32(5):610-621. https://DOI:1007/s11096-010-9400-2.
    CrossRef
29. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. 2000;25(24):3186-3191.
    CrossRef
30. Jordan Pharmaceutical Association. Drug and pharmacy law No 13. website. https://www.jpa.org.jo/page-1. Published 2013. Accessed 2020,May.
31. Duckett S. Expanding the breadth of Medicare: learning from Australia. Health Economics, Policy and Law. 2018;13(3-4):344-368. https://Doi:10.1017/S1744133117000421.
    CrossRef
32. Nusair MB, Hijazi BM, Jalaileh RA, Naji EA, Mohd HA. Pharmacists’ readiness to adopt prescribing authority in Jordan. Journal of Pharmaceutical Health Services Research. 2020;11(3):255-260. https://DOI:1111/jphs.12355.
    CrossRef
33. Diab MI, Ibrahim A, Abdallah O, et al. Perspectives of future pharmacists on the potential for development and implementation of pharmacist prescribing in Qatar. International Journal of Clinical Pharmacy. 2020:1-14. https://DOI:1007/s11096-019-00946-9.
    CrossRef
34. George J, Pfleger D, McCaig D, Bond C, Stewart D. Independent prescribing by pharmacists: a study of the awareness, views and attitudes of Scottish community pharmacists. Pharmacy World and Science. 2006;28(2):45-53. https://DOI:1007/s11096-006-9018-6.
    CrossRef
35. Atkinson J, Sánchez Pozo A, Rekkas D, et al. Hospital and community pharmacists’ perceptions of which competences are important for their practice. 2016;4(2):21. https://DOI:10.3390/pharmacy4020021.
    CrossRef
36. Hoti K, Hughes J, Sunderland B. Expanded prescribing: a comparison of the views of Australian hospital and community pharmacists. International journal of clinical pharmacy. 2013;35(3):469-475. https://DOI:1007/s11096-013-9766-z.
    CrossRef
37. Ajabnoor AM, Cooper RJ. Pharmacists’ Prescribing in Saudi Arabia: Cross-Sectional Study Describing Current Practices and Future Perspectives. 2020;8(3):160. https://DOI:10.3390/pharmacy8030160.
    CrossRef
38. Hoti K, Hughes J, Sunderland B. An expanded prescribing role for pharmacists-an Australian perspective. The Australasian medical journal. 2011;4(4):236. https://DOI:10.4066/AMJ.2011.694.
    CrossRef
39. Jebara T. A study of the development of frameworks of pharmacist prescribing in Qatar Website: https://rgu-repository.worktribe.com/output/638195. Published 2019. Accessed 2020, May.
40. Alghamdi SSA, Hodson K, Deslandes P, et al. Prescribing trends over time by non-medical independent prescribers in primary care settings across Wales (2011–2018): a secondary database analysis. BMJ open. 2020;10(10):e036379. https://DOI:1136/bmjopen-2019-036379.
    CrossRef
41. Nazer LH, Tuffaha H. Health care and pharmacy practice in Jordan. The Canadian journal of hospital pharmacy. 2017;70(2):150. https://Doi: 4212/cjhp.v70i2.1649
    CrossRef
42. Almaaytah A, Mukattash TL, Hajaj J. Dispensing of non-prescribed antibiotics in Jordan. Patient preference and adherence. 2015;9:1389. https://Doi: 2147/PPA.S91649.
    CrossRef
43. Basheti IA, Tadros OK, Aburuz S. Value of a community‐based medication management review service in Jordan: a prospective randomized controlled study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2016;36(10):1075-1086. https://org/10.1002/phar.1833.
    CrossRef
44. Aje AA, Okhamafe AO. Knowledge, attitude and perception on PharmD program among penultimate and final-year undergraduate pharmacy students in a Nigerian university–An intervention study. Tropical Journal of Pharmaceutical Research. 2020;19(2):383-389. https://DOI: 4314/tjpr.v19i2.22.
    CrossRef
45. Brown DL. It is time to rethink the all‐Pharm. D. educational system: Multiple tiered degrees would better serve the diverse nature of pharmacy practice. Journal of the American College of Clinical Pharmacy. 2020;3(6):1147-1154. https://DOI:1002/jac5.1287.
    CrossRef

(Visited 959 times, 1 visits today)